All cancer types
Results
Phase 1
This trial looked at a drug called ceralasertib (AZD6738) for people who have an advanced solid tumour. are any type of cancer apart from leukaemia or lymphoma.
You pronounce ceralasertib as sir-al-a-ser-tib.
Cancer Research UK supported this trial.
The trial was open for people to join between 2014 and 2020. The team published the results in 2024.
Recruitment start: 7 July 2014
Recruitment end: 31 July 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Kevin Harrington
AstraZeneca
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Institute of Cancer Research (ICR)
NIHR Clinical Research Network: Cancer
Rosetrees Trust
The Royal Marsden NHS Foundation Trust
This is Cancer Research UK trial number CRUKD/14/007.
Last reviewed: 24 October 2024
CRUK internal database number: 12171
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
